Octarine Bio
Latest round
- Series A
Last raised
- Dec 2025
Total raised
- $5.9M
Investors
- 7
About Octarine Bio
Octarine Bio ApS is a Danish company specializing in synthetic biology solutions that provide sustainable, bio-based products to meet global challenges, focusing on advanced enzyme technology and precision fermentation processes. Founded in 2018 in Copenhagen, Denmark, Octarine Bio ApS focuses on developing sustainable bioproducts. It was founded by Nethaji Gallage (CEO), and Nick Milne (CSO). Octarine Bio specializes in synthetic biology solutions, offering advanced enzyme technology and the PurePalette™ precision fermentation process to create custom microbes for various bio-based ingredients. These include textile dyes, skincare components, and health supplements, focusing on reducing environmental impact. Their offerings are relevant to sectors such as textiles, cosmetics, and nutritional supplements, addressing the needs of manufacturers seeking sustainable practices across Europe, North America, and Asia. Octarine Bio generates revenue through strategic partnerships and direct B2B sales, primarily focusing on its flagship PurePalette™ dye products. Collaborating with manufacturers, they integrate these dyes into existing production frameworks, emphasizing sustainability in client supply chains. Pricing structures are tailored according to client requirements, promoting long-term partnerships. Looking ahead, Octarine Bio plans to launch new products leveraging its precision fermentation technology, with specific timelines for integration into existing markets.
Who invested in Octarine Bio
7 investors across 1 round
See all investors in Octarine Bio
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Dec 23, 2025
Amount
$5.9M
Investors
Questions about Octarine Bio
Who invested in Octarine Bio?
Octarine Bio has 7 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Octarine Bio raised?
Octarine Bio has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Octarine Bio last raise money?
Octarine Bio's most recent round on record is a Series A, in Dec 2025.
What does Octarine Bio do?
Octarine Bio ApS is a Danish company specializing in synthetic biology solutions that provide sustainable, bio-based products to meet global challenges, focusing on advanced enzyme technology and precision fermentation processes.
Where is Octarine Bio headquartered?
Octarine Bio is headquartered in Copenhagen, Denmark.
Which VCs invest in companies like Octarine Bio?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Highland Europe back biotechnology companies at Octarine Bio's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Octarine Bio? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.